Pomalyst and Cyanocobalamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pomalyst (pomalidomide) and Cyanocobalamin (cyanocobalamin). Common drug interactions include atrial fibrillation among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Pomalyst and Cyanocobalamin. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Pomalyst?

Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.

What is Cyanocobalamin?

Cyanocobalamin has active ingredients of cyanocobalamin. It is often used in vitamin b12 deficiency. eHealthMe is studying from 14,651 Cyanocobalamin users. Check the latest studies of Cyanocobalamin.



On Jul, 05, 2026

76 people who take Pomalyst and Cyanocobalamin together, and have interactions are studied.

Pomalyst and Cyanocobalamin drug interactions.

What are the common drug interactions of Pomalyst and Cyanocobalamin, by gender? *:

female:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  3. Cough
  4. Dysgeusia (disorder of the sense of taste)
  5. Dyspnoea (difficult or laboured respiration)
  6. Eating disorder
  7. Full blood count decreased
  8. Infection
  9. Pain of skin
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

male:

  1. White blood cell count decreased
  2. Fatigue (feeling of tiredness)
  3. Oral disorder (mouth disease)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Renal disorder (kidney disease)
  6. Adverse drug reaction
  7. Gait disturbance
  8. Pain in extremity
  9. Parainfluenzae virus infection
  10. Acute lymphocytic leukaemia (cancer of the white blood cells)

What are the common drug interactions of Pomalyst and Cyanocobalamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Vomiting
  2. Constipation
  3. Influenza
  4. Nausea (feeling of having an urge to vomit)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Death
  7. Renal failure (kidney dysfunction)

60+:

  1. Fatigue (feeling of tiredness)
  2. Diarrhoea
  3. Asthenia (weakness)
  4. White blood cell count decreased
  5. Dry mouth
  6. Sinusitis (inflammation of sinus)
  7. Swelling face
  8. Vision blurred
  9. Platelet count decreased
  10. Gastric disorder (disease of stomach)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 71 people, 93.42%
  2. Pain: 4 people, 5.26%
  3. Diarrhea: 4 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pomalyst and Cyanocobalamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pomalyst and Cyanocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pomalyst:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cyanocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pomalyst and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyanocobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pomalidomide and cyanocobalamin (the active ingredients of Pomalyst and Cyanocobalamin, respectively), and Pomalyst and Cyanocobalamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: